Cargando…

Long‐term antagonism and allosteric regulation of mu opioid receptors by the novel ligand, methocinnamox

Opioid overdose is a leading cause of death in the United States. The only treatment available currently is the competitive antagonist, naloxone (Narcan(®)). Although naloxone is very effective and has saved many lives, as a competitive antagonist it has limitations. Due to the short half‐life of na...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zamora, Joshua C., Smith, Hudson R., Jennings, Elaine M., Chavera, Teresa S., Kotipalli, Varun, Jay, Aleasha, Husbands, Stephen M., Disney, Alex, Berg, Kelly A., Clarke, William P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8554411/ https://www.ncbi.nlm.nih.gov/pubmed/34713624 http://dx.doi.org/10.1002/prp2.887

Ejemplares similares

The Potential of Methocinnamox as a Future Treatment for Opioid Use Disorder: A Narrative Review
por: Jordan, Colleen G., et al.
Publicado: (2022)

Anti-Analgesic Effect of the Mu/Delta Opioid Receptor Heteromer Revealed by Ligand-Biased Antagonism
por: Milan-Lobo, Laura, et al.
Publicado: (2013)

A novel alternatively spliced isoform of the mu-opioid receptor: functional antagonism
por: Gris, Pavel, et al.
Publicado: (2010)

Opioid antagonism in humans: a primer on optimal dose and timing for central mu-opioid receptor blockade
por: Trøstheim, Martin, et al.
Publicado: (2022)

Ligand-Specific Regulation of the Endogenous Mu-Opioid Receptor by Chronic Treatment with Mu-Opioid Peptide Agonists
por: Murányi, Marianna, et al.
Publicado: (2013)

Activity of opioid ligands in cells expressing cloned mu opioid receptors
por: Gharagozlou, Parham, et al.
Publicado: (2003)

Nitro-benzylideneoxymorphone, a bifunctional mu and delta opioid receptor ligand with high mu opioid receptor efficacy
por: Olson, Keith M., et al.
Publicado: (2023)

The novel use of mu-opioid receptor antagonism for the treatment of refractory pruritus in Kyrle’s disease()()
por: Forouzandeh, Mahtab, et al.
Publicado: (2019)

Allosteric Antagonism of the A(2A) Adenosine Receptor by a Series of Bitopic Ligands
por: Gao, Zhan-Guo, et al.
Publicado: (2020)

Orvinols with Mixed Kappa/Mu Opioid Receptor Agonist Activity
por: Greedy, Benjamin M., et al.
Publicado: (2013)

Opioid Antagonists from the Orvinol Series as Potential Reversal Agents for Opioid Overdose
por: Disney, Alex, et al.
Publicado: (2022)

Selectively Promiscuous Opioid Ligands: Discovery of High Affinity/Low Efficacy Opioid Ligands with Substantial Nociceptin Opioid Peptide Receptor Affinity
por: Kumar, Vinod, et al.
Publicado: (2014)

Measuring ligand efficacy at the mu-opioid receptor using a conformational biosensor
por: Livingston, Kathryn E, et al.
Publicado: (2018)

In Vitro Effects of Ligand Bias on Primate Mu Opioid Receptor Downstream Signaling
por: Zhang, Xiao, et al.
Publicado: (2020)

Allosteric Antagonism of Insect Odorant Receptor Ion Channels
por: Jones, Patrick L., et al.
Publicado: (2012)

Bispecific sigma-1 receptor antagonism and mu-opioid receptor partial agonism: WLB-73502, an analgesic with improved efficacy and safety profile compared to strong opioids
por: Vidal-Torres, Alba, et al.
Publicado: (2023)

Allosteric Antagonism of the Pregnane X Receptor (PXR): Current-State-of-the-Art and Prediction of Novel Allosteric Sites
por: Kamaraj, Rajamanikkam, et al.
Publicado: (2022)

The novel μ‐opioid receptor agonist PZM21 depresses respiration and induces tolerance to antinociception
por: Hill, Rob, et al.
Publicado: (2018)

Molecular characterization of eluxadoline as a potential ligand targeting mu-delta opioid receptor heteromers
por: Fujita, Wakako, et al.
Publicado: (2014)

Heteromerization of Endogenous Mu and Delta Opioid Receptors Induces Ligand-Selective Co-Targeting to Lysosomes
por: Derouiche, Lyes, et al.
Publicado: (2020)

Dezocine is a Biased Ligand without Significant Beta-Arrestin Activation of the mu Opioid Receptor
por: Grothusen, John, et al.
Publicado: (2022)

Argon blocks the expression of locomotor sensitization to amphetamine through antagonism at the vesicular monoamine transporter-2 and mu-opioid receptor in the nucleus accumbens
por: David, H N, et al.
Publicado: (2015)

CXCR2 chemokine receptor antagonism enhances DOP opioid receptor function via allosteric regulation of the CXCR2–DOP receptor heterodimer
por: Parenty, Geraldine, et al.
Publicado: (2008)

Probing ligand recognition of the opioid pan antagonist AT-076 at nociceptin, kappa, mu, and delta opioid receptors through structure-activity relationships
por: Journigan, V. Blair, et al.
Publicado: (2017)

Pharmacological augmentation of nicotinamide phosphoribosyltransferase (NAMPT) protects against paclitaxel-induced peripheral neuropathy
por: LoCoco, Peter M, et al.
Publicado: (2017)

Facial mimicry is not modulated by dopamine D2/3 and opioid receptor antagonism
por: Korb, Sebastian, et al.
Publicado: (2023)

Ligand-Directed Functional Selectivity at the Mu Opioid Receptor Revealed by Label-Free Integrative Pharmacology On-Target
por: Morse, Megan, et al.
Publicado: (2011)

Convallatoxin enhance the ligand-induced mu-opioid receptor endocytosis and attenuate morphine antinociceptive tolerance in mice
por: Chao, Po-Kuan, et al.
Publicado: (2019)

Kappa opioid receptor antagonism: Are opioids the answer for treatment resistant depression?
por: Peckham, Alyssa M., et al.
Publicado: (2018)

Allosteric inhibition of the T cell receptor by a designed membrane ligand
por: Ye, Yujie, et al.
Publicado: (2023)

C7β-Methyl Analogues of the Orvinols: The Discovery of Kappa Opioid Antagonists with Nociceptin/Orphanin FQ Peptide (NOP) Receptor Partial Agonism and Low, or Zero, Efficacy at Mu Opioid Receptors
por: Cueva, Juan Pablo, et al.
Publicado: (2015)

Mu Opioid Receptor Gene: New Point Mutations in Opioid Addicts
por: Dinarvand, Amin, et al.
Publicado: (2014)

Targeting opioid receptor signaling in depression: do we need selective κ opioid receptor antagonists?
por: Bailey, Sarah J., et al.
Publicado: (2018)

Activation mechanism of the μ-opioid receptor by an allosteric modulator
por: Kaneko, Shun, et al.
Publicado: (2022)

Mu Opioid Receptor Actions in the Lateral Habenula
por: Margolis, Elyssa B., et al.
Publicado: (2016)

Interaction of the mu-opioid receptor with GPR177 (Wntless) inhibits Wnt secretion: potential implications for opioid dependence
por: Jin, Jay, et al.
Publicado: (2010)

Dual Allosteric Effect in Glycine/NMDA Receptor Antagonism: A Comparative QSAR Approach
por: Sharma, Manish, et al.
Publicado: (2010)

Heterodimerization of Mu Opioid Receptor Protomer with Dopamine D(2) Receptor Modulates Agonist-Induced Internalization of Mu Opioid Receptor
por: Vasudevan, Lakshmi, et al.
Publicado: (2019)

Alternative Pre-mRNA Splicing of the Mu Opioid Receptor Gene, OPRM1: Insight into Complex Mu Opioid Actions
por: Liu, Shan, et al.
Publicado: (2021)

Opioid antagonism modulates wanting-related frontostriatal connectivity
por: Soutschek, Alexander, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_rivnstbampa13p6ndgmh6m4vlm